Patent Assignment
Reel/Frame 016452/0379
Assignment of Assignor's Interest
Recorded: 2005-08-25
Pages: 4
Assignors
LI, FENGZHI
Executed: 2005-02-08
LING, XIANG
Executed: 2005-02-15
RUSTUM, YOUCEF
Executed: 2005-02-17
Assignee
HEALTH RESEARCH, INC.
ROSWELL PARK CANCER INSTITUTE, ELM AND CARLTON STREETS, BUFFALO, NEW YORK, 14263
Covered Property
(1)
Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents
Application:
10/997,784 →
Publication:
US 2005/0250854
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Merger
Jun 7, 2005
From: TULARIK INC.
To: ARROW ACQUISITION, LLC
Reel/Frame 016309/0003 →
Change of Name
Jun 7, 2005
From: ARROW ACQUISITION, LLC
To: AMGEN SF, LLC
Reel/Frame 016309/0812 →
Assignment of Assignor's Interest
Aug 26, 2005
From: SCHWENDNER, SUSAN; WALLING, JACQUELINE; TIMMERMANS, PIETER
To: AMGEN INC
Reel/Frame 016455/0904 →
Assignment of Assignor's Interest
Oct 18, 2005
From: AMGEN SF, LLC
To: AMGEN INC.
Reel/Frame 016871/0736 →
Assignment of Assignor's Interest
Jun 25, 2007
From: HEALTH RESEARCH, INC. ROSWELL PARK CANCER INSTITUTE
To: AMGEN INC.
Reel/Frame 019472/0893 →